Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Alvogen, Inc. Company Profile

20:05 EDT 20th April 2014 | BioPortfolio

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic selection of products, partners and markets, and the utilization of a consolidated global supply chain. The company has more than 130 pharmaceutical products in development and registration with several products expected to be launched in 2010. The product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of Oncology, Cardiology, Respiratory, Neurology and Gastroenterology.


News Articles [27 Associated News Articles listed on BioPortfolio]

Partial M&A between Alvogen and Lotus

U.S. pharmaceutical company Alvogen has agreed for partial m&a by buying a 67 percent stake in Taiwan’s Lotus Pharmaceutical  for $200 million. Alvogen would pay T$39.5 ($1.3) a share via a...

Alvogen Pays $210 Million for 67% of Taiwan’s Lotus Pharma

Alvogen, a multinational maker of complex generic drugs, will buy 67% of Taiwan’s Lotus Pharmaceutical for $210 million. Lotus makes generic oral and injection drugs in a wide variety of therape...

Alvogen pays $200m for majority share of Taiwan's Lotus

US-based Alvogen has reportedly agreed to acquire a 67% stake in Taiwanese Lotus Pharmaceutical at a price of $200m.

U.S.-based Alvogen agrees to buy Taiwan's Lotus for $200 mln-paper

TAIPEI, Dec 17 (Reuters) - U.S. pharmaceutical company Alvogen has agreed to buy a 67 percent stake in Taiwan's Lotus Pharmaceutical Co. for $200 million, a local newspaper reported on Tuesday.

Alvogen takes 67% stake in Lotus Pharma

Privately-owned US generics firm Alvogen revealed that, last month, it agreed to become the majority shareholder in Taiwanese Lotus Pharmaceuticals through a private placement of newly issued shares,...

Alvogen launches infliximab biosimilar in Europe

US generics company Alvogen announced on 13 February 2014 that it had launched the infliximab biosimilar Inflectra in Central and Eastern Europe in collaboration with Hospira.

Pamplona buys majority stake in US generic firm Alvogen

Pamplona Capital Management has as acquired a majority stake in privately-held US company Alvogen, which it says is one of the fastest growing generics companies in the pharmaceutical industry.

Lotus pours $200m back into Alvogen to buy Asian businesses

Alvogen and Lotus Pharmaceuticals have become further entwined after Lotus has agreed to acquire several of Alvogen's businesses in Asia using the money gained from Alvogen's purchase of a 67% stake i...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen, Inc." on BioPortfolio

We have published hundreds of Alvogen, Inc. news stories on BioPortfolio along with dozens of Alvogen, Inc. Clinical Trials and PubMed Articles about Alvogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen, Inc. Companies in our database. You can also find out about relevant Alvogen, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement